In line, COVID-19 plasma was able to induce the production of bioactive TF in cultured lung fibroblasts and this was severely diminished after treatment with DNase I, pointing towards an involvement of circulating NETs in COVID-19 plasma in sustaining the coagulation cascade (169). The gene discussed is TF; the disease is COVID-19.